ZA981123B - Microgranules containing cisplastin manufacturing process pharmaceutical preparation and use in polychemotherapy or in combination with a radiotherapy - Google Patents

Microgranules containing cisplastin manufacturing process pharmaceutical preparation and use in polychemotherapy or in combination with a radiotherapy

Info

Publication number
ZA981123B
ZA981123B ZA981123A ZA981123A ZA981123B ZA 981123 B ZA981123 B ZA 981123B ZA 981123 A ZA981123 A ZA 981123A ZA 981123 A ZA981123 A ZA 981123A ZA 981123 B ZA981123 B ZA 981123B
Authority
ZA
South Africa
Prior art keywords
cisplastin
polychemotherapy
radiotherapy
combination
manufacturing process
Prior art date
Application number
ZA981123A
Other languages
English (en)
Inventor
Patrice Debregeas
Gerard Leduc
Pascal Oury
Pascal Suplie
Original Assignee
Ethypharm Lab Prod Ethiques
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ethypharm Lab Prod Ethiques filed Critical Ethypharm Lab Prod Ethiques
Publication of ZA981123B publication Critical patent/ZA981123B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/167—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface
    • A61K9/1676—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface having a drug-free core with discrete complete coating layer containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/243—Platinum; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
ZA981123A 1997-02-11 1998-02-11 Microgranules containing cisplastin manufacturing process pharmaceutical preparation and use in polychemotherapy or in combination with a radiotherapy ZA981123B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9701545A FR2759293B1 (fr) 1997-02-11 1997-02-11 Microgranules contenant du cisplatine, procede de fabrication, preparation pharmaceutique et utilisation en polychimiotherapie ou en association avec une radiotherapie

Publications (1)

Publication Number Publication Date
ZA981123B true ZA981123B (en) 1998-08-20

Family

ID=9503556

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA981123A ZA981123B (en) 1997-02-11 1998-02-11 Microgranules containing cisplastin manufacturing process pharmaceutical preparation and use in polychemotherapy or in combination with a radiotherapy

Country Status (24)

Country Link
US (2) US6458389B1 (ru)
EP (1) EP0971702B1 (ru)
JP (1) JP4549445B2 (ru)
KR (1) KR100471672B1 (ru)
AR (1) AR011133A1 (ru)
AT (1) ATE255409T1 (ru)
BG (1) BG64247B1 (ru)
BR (1) BR9807319A (ru)
CA (1) CA2282082C (ru)
DE (1) DE69820239T2 (ru)
DK (1) DK0971702T3 (ru)
EA (1) EA001760B1 (ru)
ES (1) ES2210726T3 (ru)
FR (1) FR2759293B1 (ru)
HU (1) HU225425B1 (ru)
IL (1) IL131326A (ru)
IN (1) IN187998B (ru)
NO (1) NO323230B1 (ru)
NZ (1) NZ337216A (ru)
PL (1) PL191631B1 (ru)
PT (1) PT971702E (ru)
TW (1) TW561055B (ru)
WO (1) WO1998034599A1 (ru)
ZA (1) ZA981123B (ru)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050096304A1 (en) * 1998-09-08 2005-05-05 David White Method of treating cancer using dithiocarbamate derivatives
FR2790668B1 (fr) * 1999-03-12 2002-07-26 D B F Granules contenant une substance vegetale et leur procede de preparation
JP2002544220A (ja) * 1999-05-17 2002-12-24 デー．ベー．エフ． 植物物質を含有する顆粒及びその製造方法
MXPA06003942A (es) * 2003-10-10 2006-07-05 Ethypharm Sa Microgranulos de liberacion sostenida que contienen extracto de gingko biloba, y procedimiento para la fabricacion de los mismos.
FR2861990B1 (fr) * 2003-11-10 2006-02-10 Nouveaux Produits Pharma Comprimes faiblement doses a reseau de polymeres
ES2306278T3 (es) * 2004-11-18 2008-11-01 Bristol-Myers Squibb Company Perla enterica recubierta que comprende ixabepilona.
EP1832293A4 (en) * 2004-12-10 2009-01-07 Tmrc Co Ltd MEANS FOR THE TREATMENT OF CANCER METASTAS AND CANNESMAS TREATMENT
US9107824B2 (en) 2005-11-08 2015-08-18 Insmed Incorporated Methods of treating cancer with high potency lipid-based platinum compound formulations administered intraperitoneally
FR2918567B1 (fr) * 2007-07-11 2012-08-03 Pf Medicament Composition pharmaceutique stable d'un sel hydrosoluble de vinorelbine.
FR2918566B1 (fr) 2007-07-11 2009-10-09 Pierre Fabre Medicament Sa Composition pharmaceutique stable d'un sel hydrosoluble de vinflunine.
SI2187875T1 (sl) * 2007-09-21 2012-12-31 Evonik Rohm Gmbh Od pH odvisen farmacevtski sestavek z nadzorovanim sproščanjem za ne-opioide z odpornostjo na vpliv etanola
KR101424653B1 (ko) * 2007-09-21 2014-08-06 에보니크 룀 게엠베하 에탄올의 영향에 대하여 내성을 가지는 ｐｈ-의존성 조절 방출 제약학적 오피오이드 조성물
KR20100103565A (ko) * 2008-01-10 2010-09-27 에보니크 룀 게엠베하 촉진되고 조절된 활성 물질 방출을 갖는 코팅된 제약학적 또는 건강기능성 제제
SI2230932T1 (sl) * 2008-01-10 2017-07-31 Evonik Roehm Gmbh Oplaščeni farmacevtski ali nutracevtski pripravek s povečanim sproščanjem aktivne učinkovine v črevesu
DK177529B1 (en) * 2009-10-23 2013-09-08 Bio Bedst Aps Liposomes with improved storage stability
CA2688202C (en) * 2009-12-11 2012-11-13 Bj Services Company Viscoelastic fluids containing hydroxyethyl cellulose
EP2371356B1 (en) * 2010-03-12 2012-12-19 Phoeme GmbH Multi-particle pharmaceutical formulation for colon absorption
US8070047B1 (en) * 2010-12-02 2011-12-06 Rohm And Haas Electronic Materials Llc Flux composition and method of soldering
CN115414384A (zh) 2012-09-04 2022-12-02 埃莱森制药有限责任公司 用顺铂脂质复合物预防癌症的肺部复发
JP6487534B2 (ja) 2014-09-05 2019-03-20 シンビオミックス セラピューティクス、エルエルシー 細菌性膣炎の治療に使用するためのセクニダゾール
US10238688B2 (en) * 2015-04-24 2019-03-26 Genedia Biotech Co., Ltd. Combination therapies for bladder cancer
WO2016196653A1 (en) * 2015-06-01 2016-12-08 Symbiomix Therapeutics, Llc Novel nitroimidazole formulations and uses thereof
CN108024955A (zh) 2015-06-12 2018-05-11 瓦克萨特公司 用于rsv和诺如病毒抗原的小肠递送的制剂
BR112020021059B1 (pt) 2018-04-24 2022-08-30 Shionogi & Co., Ltd Forma de dosagem sólida
MX2020011130A (es) * 2018-04-24 2022-09-09 Shionogi & Co Forma de dosificacion solida que tiene excelente estabilidad.

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0059817B1 (fr) * 1981-03-11 1985-10-09 Mirko Beljanski Serpentine; alstonine et sempervirine, médicaments inhibant spécifiquement les cellules cancéreuses et tumorales
IT1153974B (it) * 1982-09-23 1987-01-21 Erba Farmitalia Composizioni farmacologiche a base di cisplatino e metodo per il loro ottenimento
DE3421468A1 (de) * 1984-06-08 1985-12-19 Dr. Rentschler Arzneimittel Gmbh & Co, 7958 Laupheim Lipidnanopellets als traegersystem fuer arzneimittel zur peroralen anwendung
DE3523454A1 (de) * 1985-07-01 1987-01-08 Eberhard Prof Dr Nuernberg Formkoerper
US4925674A (en) * 1988-08-25 1990-05-15 Himedics, Inc. Amoxicillin microencapsulated granules
US5399363A (en) * 1991-01-25 1995-03-21 Eastman Kodak Company Surface modified anticancer nanoparticles
JPH05294839A (ja) * 1992-04-20 1993-11-09 Biomaterial Universe Kk シスプラチン含有生体内分解吸収性高分子の微小球お よびその製造法
US5795882A (en) * 1992-06-22 1998-08-18 Bone Care International, Inc. Method of treating prostatic diseases using delayed and/or sustained release vitamin D formulations
JPH07112932A (ja) * 1993-08-27 1995-05-02 Mitsui Toatsu Chem Inc 徐放性医薬製剤
JPH0789849A (ja) * 1993-09-20 1995-04-04 Fujisawa Pharmaceut Co Ltd 徐放性製剤
JPH0859460A (ja) * 1994-08-22 1996-03-05 Tanaka Kikinzoku Kogyo Kk 抗ガン剤内包キトサンミクロスフェア及びその製造法
US5637319A (en) * 1995-03-01 1997-06-10 Takada; Kanji Controlled-release preparations
US5614206A (en) * 1995-03-07 1997-03-25 Wright Medical Technology, Inc. Controlled dissolution pellet containing calcium sulfate
JP2001501173A (ja) * 1996-08-23 2001-01-30 アルザ コーポレイション シスプラチン化合物を含有するリポソーム

Also Published As

Publication number Publication date
HUP0001719A3 (en) 2005-11-28
IL131326A0 (en) 2001-01-28
CA2282082C (fr) 2005-10-18
FR2759293B1 (fr) 1999-04-30
NZ337216A (en) 2000-09-29
ATE255409T1 (de) 2003-12-15
BG103647A (en) 2000-03-31
EA001760B1 (ru) 2001-08-27
HUP0001719A2 (hu) 2000-11-28
JP2001512433A (ja) 2001-08-21
PL335107A1 (en) 2000-04-10
BG64247B1 (bg) 2004-07-30
JP4549445B2 (ja) 2010-09-22
PT971702E (pt) 2004-04-30
DE69820239T2 (de) 2004-10-07
PL191631B1 (pl) 2006-06-30
EP0971702A1 (fr) 2000-01-19
DE69820239D1 (de) 2004-01-15
KR20000070997A (ko) 2000-11-25
KR100471672B1 (ko) 2005-03-07
WO1998034599A1 (fr) 1998-08-13
HU225425B1 (en) 2006-11-28
ES2210726T3 (es) 2004-07-01
IN187998B (ru) 2002-08-03
DK0971702T3 (da) 2004-04-13
BR9807319A (pt) 2000-04-18
US6458389B1 (en) 2002-10-01
NO323230B1 (no) 2007-02-05
US20030017210A1 (en) 2003-01-23
TW561055B (en) 2003-11-11
EA199900734A1 (ru) 2000-04-24
NO993881L (no) 1999-09-29
CA2282082A1 (fr) 1998-08-13
AU6626798A (en) 1998-08-26
FR2759293A1 (fr) 1998-08-14
AU744001B2 (en) 2002-02-14
EP0971702B1 (fr) 2003-12-03
NO993881D0 (no) 1999-08-11
IL131326A (en) 2005-03-20
AR011133A1 (es) 2000-08-02

Similar Documents

Publication Publication Date Title
ZA981123B (en) Microgranules containing cisplastin manufacturing process pharmaceutical preparation and use in polychemotherapy or in combination with a radiotherapy
GB9721437D0 (en) Heteroaromatic compounds and their use in medicine
ZA9810882B (en) A medicament in soft pellet form and processes therefor
GB9401026D0 (en) Solutions and their preparation
HK1027024A1 (en) Polymer coated tablet comprising amoxycillin and clavunalate
AU7673694A (en) Simultaneous angioplasty and drug delivery
GB2303048B (en) A method of manufacturing fastener-device elements and elements manufactured in accordance with the method
HU9602104D0 (en) Novel medicines and their use
ZA953879B (en) Protein production and protein delivery
EP0415758A3 (en) Stretchable laminate constructions and manufacturing process
PL327610A1 (en) Quinoline and quinozoline compounds useful in therapy
HUP0003656A2 (en) Therapeutic combinations comprising amlodipin and atorvastatin
AU5127098A (en) Use of a combination of penciclovir and alpha-interferon in the manufacture of a medicament for the treatment of hepatitis
HUP0001063A3 (en) Use of green porphyrins in the manufacture of a medicament treating atherosclerosis
AU7216996A (en) A paf-acetylhydrolase and use in therapy
PL332696A1 (en) Carriers containing a combination of enterolipoid and of a lipoid of complementary shape and their therapeutic applications
PL338123A1 (en) 6-pyrrolydin-2-ylpyridines, their production and application in therapy
GB9302553D0 (en) Pharmaceutical preparations and their manufacture and use
ZA942884B (en) 2-amino-4-heteroaryl-1. 4-dihydropyridines processes for their preparation and their use in medicaments
IL114098A0 (en) Diamines their manufacture and medicaments containing them
ZA942881B (en) Quinolyl-dihydropyridine esters processes fot their preparation and their use in medicaments
PL334441A1 (en) Method of manufacturing a rigid coloured article and article manufactured thereby
GB2334664B (en) A method of manufacturing fastener-device elements and elements manufactured in accordance with the method
ZA942879B (en) 2-amino-5-cyano-4-quinolyidihydropyridine esters processes for their preparation and their use in medicaments
GB9419895D0 (en) Packages and their manufacture